These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 33147750)

  • 1. The Emerging Role of the Lysosome in Parkinson's Disease.
    Navarro-Romero A; Montpeyó M; Martinez-Vicente M
    Cells; 2020 Nov; 9(11):. PubMed ID: 33147750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
    Xilouri M; Brekk OR; Stefanis L
    Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging autophagic endo-lysosomal targets in the management of Parkinson's disease.
    Siddiqui T; Bhatt LK
    Rev Neurol (Paris); 2024 Jun; 180(6):477-485. PubMed ID: 37586941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
    Wong YC; Krainc D
    Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
    Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
    Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson's Disease.
    Blumenreich S; Barav OB; Jenkins BJ; Futerman AH
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.
    Bellomo G; Paciotti S; Gatticchi L; Parnetti L
    Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagic- and Lysosomal-Related Biomarkers for Parkinson's Disease: Lights and Shadows.
    Xicoy H; Peñuelas N; Vila M; Laguna A
    Cells; 2019 Oct; 8(11):. PubMed ID: 31731485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association.
    Teixeira M; Sheta R; Idi W; Oueslati A
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
    Filippini A; Gennarelli M; Russo I
    Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal impairment in Parkinson's disease.
    Dehay B; Martinez-Vicente M; Caldwell GA; Caldwell KA; Yue Z; Cookson MR; Klein C; Vila M; Bezard E
    Mov Disord; 2013 Jun; 28(6):725-32. PubMed ID: 23580333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Consequences of GBA Deficiency in the Autophagy-Lysosome System in Parkinson's Disease Associated with GBA.
    Pradas E; Martinez-Vicente M
    Cells; 2023 Jan; 12(1):. PubMed ID: 36611984
    [No Abstract]   [Full Text] [Related]  

  • 17. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.
    Xilouri M; Vogiatzi T; Vekrellis K; Stefanis L
    Autophagy; 2008 Oct; 4(7):917-9. PubMed ID: 18708765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
    Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
    Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
    Dermentzaki G; Dimitriou E; Xilouri M; Michelakakis H; Stefanis L
    PLoS One; 2013; 8(4):e60674. PubMed ID: 23580063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillar α-synuclein toxicity depends on functional lysosomes.
    Guiney SJ; Adlard PA; Lei P; Mawal CH; Bush AI; Finkelstein DI; Ayton S
    J Biol Chem; 2020 Dec; 295(51):17497-17513. PubMed ID: 33453994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.